Post by
WallstreetGuru on Jun 12, 2023 11:52am
NR
Lucy bold move in acquiring SANA-013 will be a game-changer for the psychedelic industry. With more research and clinical trials, we will be sure to see a product in the market.
Comment by
Investigo on Jun 12, 2023 3:12pm
I can't help but feel a surge of anticipation for its arrival in the market. With $LSDI at the helm, I have no doubt that SANA-013 will make waves and contribute to the ever-evolving landscape of psychedelic medicine. We only need to be patient enough.
Comment by
WallstreetGuru on Jun 12, 2023 3:22pm
The acquisition is good for lucy. The psychedelics stocks can move big with a drug announcement which is what I am expecting here. The additions LSDI is making are ment to push lucy to the next level.